A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Mammalian cells respond to changes in oxygen availability through a conserved pathway that is regulated by the hypoxia-inducible factor (HIF). The alpha subunit of HIF is targeted for degradation under normoxic conditions by a ubiquitin-ligase complex that recognizes a hydroxylated proline residue in HIF. We identified a conserved family of HIF prolyl hydoxylase (HPH) enzymes that appear to be responsible for this posttranslational modification. In cultured mammalian cells, inappropriate accumulation of HIF caused by forced expression of the HIF-1α subunit under normoxic conditions was attenuated by coexpression of HPH. Suppression of HPH in cultured Drosophila melanogaster cells by RNA interference resulted in elevated expression of a hypoxia-inducible gene ( LDH , encoding lactate dehydrogenase) under normoxic conditions. These findings indicate that HPH is an essential component of the pathway through which cells sense oxygen.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The two proline residues (P402/ P564) located in the LXXLAP amino acid motif in the ODDD of HIF-1α were found to be good substrates for the action of a group of enzymes called prolyl-4-hydroxylases (PHDs) or HIF-1 prolyl hydroxylases (HPH)22, 28.”
From HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) · cites this paper as [22]
In the citing paper
“Oxygen sensing is mediated primarily by prolyl hydroxylase domain-containing proteins (PHDs), iron- and ascorbate-dependent enzymes in the 2-oxoglutarate (2-OG)–dependent dioxygenase family”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [43]
In the citing paper
“These enzymes are essential for repressing HIF signaling in an oxygen-dependent manner [42,43]”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [43]
In the citing paper
“Under normoxic conditions, prolyl hydroxylase enzymes (EGLN 1–3, also known as PHD 1–3) use oxygen as a substrate to hydroxylate key proline residues within the HIF-1 and HIF-2 α subunits”
From Hypoxic control of metastasis (2016) · cites this paper as [8]
In the citing paper
“Hypoxia activates HIF signaling by promoting the protein stability of HIF-α subunits.”
From Hypoxic control of metastasis (2016) · cites this paper as [8]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914
Salceda, S., & Caro, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22642 · Cited by 1,674
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Cited by
Items 301–400 of 1,022
Eisenhofer, G., Huynh, T.-T., Pacak, K., Brouwers, F. M., Walther, M. M., Linehan, W. M., Munson, P. J., Mannelli, M., Goldstein, D. S., & Elkahloun, A. G. (2004) · Endocrine-Related Cancer · doi:10.1677/erc.1.00838 · Cited by 207
“…identified to date regulate hypoxia-driven processes by catalyzing the hydroxylation of key proline residues on the HIF-a subunits, thereby facilitating recognition of these transcription factors by the VHL tumor suppressor protein for proteasome-mediated degradation (Bruick & McKnight 2001).”
HIF2α Acts as an mTORC1 Activator through the Amino Acid Carrier SLC7A5
Elorza, A., Soro-Arnáiz, I., Meléndez-Rodríguez, F., Rodríguez-Vaello, V., Marsboom, G., de Cárcer, G., Acosta-Iborra, B., Albacete-Albacete, L., Ordóñez, A., Serrano-Oviedo, L., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.017 · Cited by 205
del Peso, L., Castellanos, M. C., Temes, E., Martín-Puig, S., Cuevas, Y., Olmos, G., & Landázuri, M. O. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308862200 · Cited by 205
Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer’s Disease
Cioffi, F., Adam, R. H. I., & Broersen, K. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190863 · Cited by 204
Activation of the HIF Prolyl Hydroxylase by the Iron Chaperones PCBP1 and PCBP2
Nandal, A., Ruiz, J. C., Subramanian, P., Ghimire-Rijal, S., Sinnamon, R. A., Stemmler, T. L., Bruick, R. K., & Philpott, C. C. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.015 · Cited by 204
Self-citationEpstein-Barr Virus Latent Membrane Protein 1 Induces Synthesis of Hypoxia-Inducible Factor 1α
Wakisaka, N., Kondo, S., Yoshizaki, T., Murono, S., Furukawa, M., & Pagano, J. S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5223-5234.2004 · Cited by 204
“The oxygen-dependent turnover of HIF-1 protein is regulated by prolyl 4-hydroxylases that modify HIF-1 at two conserved proline residues (Pro-402 and Pro-564) located in the oxygen-dependent degradation domain of the protein ( 5 , 51).”
BackgroundPreconditioning in neuroprotection: From hypoxia to ischemia
Li, S., Hafeez, A., Noorulla, F., Geng, X., Shao, G., Ren, C., Lu, G., Zhao, H., Ding, Y., & Ji, X. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.01.001 · Cited by 203
“Under physiologic conditions, HIF-1α is hydroxylated by the PHD family (Bruick and McKnight, 2001; Epstein et al., 2001).”
BackgroundOrtiz-Barahona, A., Villar, D., Pescador, N., Amigo, J., & del Peso, L. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp1205 · Cited by 202
“In normoxia, HIFa is hydroxylated at two proline residues (6,7) by a family of dioxygenases (EGL nine homologs, EGLNs) that require oxygen as cosubstrate (8,9).”
BackgroundZhang, Q., Tang, X., Lu, Q. Y., Zhang, Z. F., Brown, J., & Le, A. D. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0198 · Cited by 202
MicroRNAs Induced During Ischemic Preconditioning
Lee, S.-T., Chu, K., Jung, K.-H., Yoon, H.-J., Jeon, D., Kang, K.-M., Park, K.-H., Bae, E.-K., Kim, M., Lee, S. K., et al. (2010) · Stroke · doi:10.1161/strokeaha.110.579649 · Cited by 202
Proteasome system of protein degradation and processing
Sorokin, A. V., Kim, E. R., & Ovchinnikov, L. P. (2009) · Biochemistry (Moscow) · doi:10.1134/s000629790913001x · Cited by 156
Pugh, C. W., & Ratcliffe, P. J. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00103-7 · Cited by 201
Regulation of gene expression by oxygen: NF-κB and HIF-1, two extremes
Michiels, C., Minet, E., Mottet, D., & Raes, M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01045-6 · Cited by 201
Hypoxic tumor microenvironment: Opportunities to develop targeted therapies
Patel, A., & Sant, S. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.04.005 · Cited by 201
“Subsequently, the HIF-1α subunit is hydroxylated by HIF-1 prolyl hydroxylase enzyme (HPH) facilitating its degradation in an oxygen-dependent manner (Bruick and McKnight, 2001, Epstein et al., 2001).”
MethodDann, C. E., Bruick, R. K., & Deisenhofer, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202614999 · Cited by 200
Self-citationOxygen in Health and Disease: Regulation of Oxygen Homeostasis-Clinical Implications
Maltepe, E., & Saugstad, O. D. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31818fc83f · Cited by 200
Yoo, Y., Kong, G., & Lee, M. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601025 · Cited by 200
“HIF-1a is hydroxylated at proline residues 402 and 564 by the recently identified family of HIF prolyl hydroxylase domain (PHD) proteins, which require O2 ( Bruick and McKnight, 2001; Epstein et al, 2001).”
MethodWarnecke, C., Griethe, W., Weidemann, A., Jürgensen, J. S., Willam, C., Bachmann, S., Ivashchenko, Y., Wagner, I., Frei, U., Wiesener, M., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-1062fje · Cited by 200
Prolyl 3-Hydroxylase 1, Enzyme Characterization and Identification of a Novel Family of Enzymes
Vranka, J. A., Sakai, L. Y., & Bächinger, H. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312807200 · Cited by 200
Bartoszewski, R., Moszyńska, A., Serocki, M., Cabaj, A., Polten, A., Ochocka, R., Dell'Italia, L., Bartoszewska, S., Króliczewski, J., Dąbrowski, M., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802650rr · Cited by 199
JUNG, Y., ISAACS, J. S., LEE, S., TREPEL, J., LIU, Z.-G., & NECKERS, L. (2003) · Biochemical Journal · doi:10.1042/bj20021279 · Cited by 198
The hypoxia‐inducible‐factor hydroxylases bring fresh air into hypoxia signalling
Berra, E., Ginouvès, A., & Pouysségur, J. (2006) · EMBO reports · doi:10.1038/sj.embor.7400598 · Cited by 196
“Within months of these initial reports, the PHDs—the enzymes catalysing the hydroxylation reaction—were identified (see Fig 1; Bruick & McKnight, 2001; Epstein et al, 2001).”
BackgroundMechanisms of adaptive angiogenesis to tissue hypoxia
Fong, G.-H. (2008) · Angiogenesis · doi:10.1007/s10456-008-9107-3 · Cited by 196
Kato, H., Tamamizu-Kato, S., & Shibasaki, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406320200 · Cited by 196
VHL protein‐interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF‐1α
Li, Z., Wang, D., Messing, E. M., & Wu, G. (2005) · EMBO reports · doi:10.1038/sj.embor.7400377 · Cited by 196
“In contrast, the O2-dependent prolyl hydroxylation is downregulated under hypoxia, resulting in HIF-1a accumulation and increased HIF-1 activity (Bruick & McKnight, 2001; Epstein et al, 2001; Ivan et al, 2001; Jaakkola et al, 2001).”
BackgroundRegulation of Transcription and Translation by Hypoxia
Liu, L., & Simon, M. C. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.6.1010 · Cited by 194
Semenza, G. L. (2006) · Experimental Physiology · doi:10.1113/expphysiol.2006.033498 · Cited by 194
“The HIF-1α prolyl hydroxylases that perform this modification (Bruick & McKnight, 2001; Epstein et al. 2001) utilize molecular O2 and α-ketoglutarate as substrates and generate succinate as a byproduct (Hewitson et al. 2004).”
BackgroundYan, Q., Bartz, S., Mao, M., Li, L., & Kaelin, W. G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01514-06 · Cited by 193
O'Hagan, K. A., Cocchiglia, S., Zhdanov, A. V., Tambuwala, M. M., Cummins, E. P., Monfared, M., Agbor, T. A., Garvey, J. F., Papkovsky, D. B., Taylor, C. T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808801106 · Cited by 193
HIF-1: the knowns and unknowns of hypoxia sensing.
Zagórska, A., & Dulak, J. (2004) · Acta Biochimica Polonica · doi:10.18388/abp.2004_3545 · Cited by 192
“Their activity, however, is distinct from the activity of procollagen prolyl hydroxylases, which belong to the same superfamily (Bruick & McKnight, 2001; Jaakkola et al., 2001).”
BackgroundRole and regulation of autophagy in cancer
Rakesh, R., PriyaDharshini, L. C., Sakthivel, K. M., & Rasmi, R. R. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166400 · Cited by 192
HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase
Sendoel, A., Kohler, I., Fellmann, C., Lowe, S. W., & Hengartner, M. O. (2010) · Nature · doi:10.1038/nature09141 · Cited by 192
Walmsley, S. R., Chilvers, E. R., Thompson, A. A., Vaughan, K., Marriott, H. M., Parker, L. C., Shaw, G., Parmar, S., Schneider, M., Sabroe, I., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43273 · Cited by 191
Zimmer, M., Ebert, B. L., Neil, C., Brenner, K., Papaioannou, I., Melas, A., Tolliday, N., Lamb, J., Pantopoulos, K., Golub, T., et al. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.12.004 · Cited by 191
Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy
Yu, T., Tang, B., & Sun, X. (2017) · Yonsei Medical Journal · doi:10.3349/ymj.2017.58.3.489 · Cited by 191
“The ODDD is important in mediating oxygen-regulated stability.(15) Either HIF-1α or HIF-2α is degradable in an oxygendependent manner through the von Hippel-Lindau protein (pVHL) pathway, and is able to complex with HIF-1β to form a heterodimer (Fig.”
Flügel, D., Görlach, A., & Kietzmann, T. (2012) · Blood · doi:10.1182/blood-2011-08-375014 · Cited by 191
Gao, N., Ding, M., Zheng, J. Z., Zhang, Z., Leonard, S. S., Liu, K. J., Shi, X., & Jiang, B.-H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200082200 · Cited by 191
Hypoxia and Hypoxia Signaling in Tissue Repair and Fibrosis
(2012) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-394307-1.00003-5 · Cited by 190
“This is mainly due to the O2-dependent hydroxylation of HIF1a amino acid proline residues, Pro and Pro, in a reaction catalyzed by HIF prolyl-4-hydroxylases (PHD) 1, 2, and 3 in presence of cofactors, O2 and 2-oxoglutarate (Bruick and McKnight, 2001).”
BackgroundHaase, V. H. (2021) · Kidney International Supplements · doi:10.1016/j.kisu.2020.12.002 · Cited by 190
Chua, Y. L., Dufour, E., Dassa, E. P., Rustin, P., Jacobs, H. T., Taylor, C. T., & Hagen, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158485 · Cited by 189
Oxygen-Regulated Gene Expression in Bovine Blastocysts1
Harvey, A. J., Kind, K. L., Pantaleon, M., Armstrong, D. T., & Thompson, J. G. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.104.028639 · Cited by 189
“HIFa proteins are continuously synthesized but are rapidly degraded by the ubiquitin-proteasome system under normoxic conditions [18, 19].”
BackgroundEvolution of the coordinate regulation of glycolytic enzyme genes by hypoxia
Webster, K. A. (2003) · Journal of Experimental Biology · doi:10.1242/jeb.00516 · Cited by 189
“The regulation of glycolytic enzyme genes by hypoxia in insects, fish, reptiles, birds and mammals and possibly all mobile multicellular species is multifactorial, with clear origins in the prokaryotic and fungal regulatory systems (Bacon et al., 1998; Bruick and McKnight, 2001; Hochachka and Lutz, 2001; Jiang, H. et…”
BackgroundInfluentialGunaratnam, L., Morley, M., Franovic, A., de Paulsen, N., Mekhail, K., Parolin, D. A. E., Nakamura, E., Lorimer, I. A. J., & Lee, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305502200 · Cited by 188
Reactive oxygen species and cellular oxygen sensing
Cash, T. P., Pan, Y., & Simon, M. C. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.07.001 · Cited by 188
Hypoxia in tissue repair and fibrosis
Darby, I. A., & Hewitson, T. D. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2461-3 · Cited by 188
Hypoxia-inducible factors link iron homeostasis and erythropoiesis
Shah, Y. M., & Xie, L. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.031 · Cited by 187
Abnormal Sympathoadrenal Development and Systemic Hypotension in PHD3−/− Mice
Bishop, T., Gallagher, D., Pascual, A., Lygate, C. A., de Bono, J. P., Nicholls, L. G., Ortega-Saenz, P., Oster, H., Wijeyekoon, B., Sutherland, A. I., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02041-07 · Cited by 187
“Though the nature of these adaptive-developmental connections remains poorly understood, it is of interest that the cellular oxygen sensor PHD3 (otherwise termed EGLN3 or HPH1), one of three Fe(II)-dependent dioxygenases now known to negatively regulate HIF by prolyl hydroxylation of HIF- subunits (HIF-1 and HIF-2) (…”
BackgroundGroulx, I., & Lee, S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5319-5336.2002 · Cited by 187
“The HIF-specific prolyl hydroxylases belong to a family of highly conserved 2-oxoglutarate-dependent oxygenases and require 2-oxoglutarate and molecular oxygen as cofactors ( 7 , 15).”
BackgroundHepatitis B virus X protein induces angiogenesis by stabilizing hypoxia‐inducible factor‐1α
Moon, E., Jeong, C., Jeong, J., Rok Kim, K., Yu, D., Murakami, S., Woo Kim, C., & Kim, K. (2004) · The FASEB Journal · doi:10.1096/fj.03-0153fje · Cited by 187
“Recently, it was reported that the Pro(402) and Asn(803) residues of HIF-1α are additional targets for hydroxylation in normoxic condition (25, 26).”
BackgroundSiderophore-mediated iron acquisition and modulation of host-bacterial interactions
Ellermann, M., & Arthur, J. C. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.489 · Cited by 186
“Under normoxic or iron-replete conditions, the alpha-subunit of the HIF heterodimer is highly unstable and is targeted for proteosomal degradation by prolyl hydroxylation [131].”
BackgroundRedox regulation of the hypoxia-inducible factor
Pouysségur, J., & Mechta-Grigoriou, F. (2006) · Biological Chemistry · doi:10.1515/bc.2006.167 · Cited by 186
“The first oxygen sensors (referred to as PHD, prolyl hydroxylase domain) regulate HIF-a protein stability (Bruick and McKnight, 2001; Epstein et al., 2001; Ivan et al., 2002).”
BackgroundStolze, I. P., Tian, Y.-M., Appelhoff, R. J., Turley, H., Wykoff, C. C., Gleadle, J. M., & Ratcliffe, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406713200 · Cited by 156
The ubiquitin‐proteasome pathway
Roos‐Mattjus, P., & Sistonen, L. (2004) · Annals of Medicine · doi:10.1080/07853890310016324 · Cited by 185
HIFs and tumors—causes and consequences
Höpfl, G., Ogunshola, O., & Gassmann, M. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00538.2003 · Cited by 185
“Three new prolyl-4-hydroxylases [named prolyl-hydroxylase domain-containing protein (PHD 1, 2, and 3); also known as HIF (prolyl hydroxylase 3, 2, and 1, respectively)] were discovered that are able to hydroxylate two HIF-1 prolin residues (Pro(402) and Pro(564)) in the presence of oxygen, ultimately leading to its de…”
BackgroundNew horizons in hypoxia signaling pathways
Pugh, C. W., & Ratcliffe, P. J. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.008 · Cited by 184
Hypoxia Inducible Factor-1–Independent Pathways in Tumor Angiogenesis
Mizukami, Y., Kohgo, Y., & Chung, D. C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0111 · Cited by 184
Katschinski, D. M., Le, L., Heinrich, D., Wagner, K. F., Hofer, T., Schindler, S. G., & Wenger, R. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110377200 · Cited by 157
Escuin, D., Kline, E. R., & Giannakakou, P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4095 · Cited by 183
“Palo Alto, CA) or pBI-GL-V6L as described previously (7, 28).”
BackgroundMethodTian, Y.-M., Yeoh, K. K., Lee, M. K., Eriksson, T., Kessler, B. M., Kramer, H. B., Edelmann, M. J., Willam, C., Pugh, C. W., Schofield, C. J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.211110 · Cited by 182
Ku, E., Vecchio, L. D., Eckardt, K., Haase, V. H., Johansen, K. L., Nangaku, M., Tangri, N., Waikar, S. S., Więcek, A., Cheung, M., et al. (2023) · Kidney International · doi:10.1016/j.kint.2023.05.009 · Cited by 182
Pagé, E. L., Chan, D. A., Giaccia, A. J., Levine, M., & Richard, D. E. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-06-0612 · Cited by 181
“Three different HIF prolyl-hydroxylases have been described, termed PHD1, PHD2, and PHD3 for their prolyl hydroxylase domain ( Bruick and McKnight, 2001; Epstein et al., 2001).”
InfluentialFunctions of the aryl hydrocarbon receptor (AHR) beyond the canonical AHR/ARNT signaling pathway
Sondermann, N. C., Faßbender, S., Hartung, F., Hätälä, A. M., Rolfes, K. M., Vogel, C. F. A., & Haarmann-Stemmann, T. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115371 · Cited by 181
HIF-1: master and commander of the hypoxic world
Mazure, N. M., Brahimi-Horn, M. C., Berta, M., Benizri, E. I., Bilton, R. L., Dayan, F., Ginouvès, A., Berra, E., & Pouysségur, J. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.04.022 · Cited by 183
HYPOXIA‐INDUCED ERYTHROPOIETIN PRODUCTION: A PARADIGM FOR OXYGEN‐REGULATED GENE EXPRESSION
Stockmann, C., & Fandrey, J. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04474.x · Cited by 153
Bao, B., Azmi, A. S., Ali, S., Ahmad, A., Li, Y., Banerjee, S., Kong, D., & Sarkar, F. H. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.04.008 · Cited by 180
“HIF proteins are the master transcriptional regulators of the cellular response to hypoxic tumor microenvironment [8,9], which are involved in the regulation of many key aspects of tumor development and progression.”
BackgroundRole of ETS Transcription Factors in the Hypoxia-Inducible Factor-2 Target Gene Selection
Aprelikova, O., Wood, M., Tackett, S., Chandramouli, G. V. R., & Barrett, J. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3345 · Cited by 155
Mu, D., Jiang, X., Sheldon, R. A., Fox, C. K., Hamrick, S. E. G., Vexler, Z. S., & Ferriero, D. M. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.020 · Cited by 179
“Under normoxic conditions, the HIF-1 subunit is hydroxylated (Bruick and McKnight, 2001; Epstein et al., 2001; Ivan et al., 2001).”
BackgroundHypoxia and HIF Signaling: One Axis with Divergent Effects
Corrado, C., & Fontana, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165611 · Cited by 179
The ubiquitin system, disease, and drug discovery
Petroski, M. D. (2008) · BMC Biochemistry · doi:10.1186/1471-2091-9-s1-s7 · Cited by 178
“Numerous biochemical and structural studies have determined that HIF1A binds to VHL when hydroxylated on two proline residues through the activity of prolyl hydroxylases, which results in its ubiquitylation and ultimate degradation [77,78,97-102].”
BackgroundHypoxia and its implications in rheumatoid arthritis
Quiñonez-Flores, C. M., González‐Chávez, S. A., & Pacheco‐Tena, C. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0281-0 · Cited by 181
“residues in the ODD domain of HIF-α [13].”
The Emerging Role of Vitamin C as a Treatment for Sepsis
Kashiouris, M. G., L’Heureux, M., Cable, C. A., Fisher, B. J., Leichtle, S. W., & Fowler, A. A. (2020) · Nutrients · doi:10.3390/nu12020292 · Cited by 177
The HIF pathway and erythrocytosis
Lee, F. S., & Percy, M. J. (2011) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130321 · Cited by 177
NQO1 inhibits proteasome-mediated degradation of HIF-1α
Oh, E.-T., Kim, J.-W., Kim, J. M., Kim, S. J., Lee, J.-S., Hong, S.-S., Goodwin, J., Ruthenborg, R. J., Jung, M. G., Lee, H.-J., et al. (2016) · Nature Communications · doi:10.1038/ncomms13593 · Cited by 176
The VHL tumor suppressor: master regulator of HIF
Haase, V. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789649394 · Cited by 175
“pVHL-mediated polyubiquitylation of HIF-α requires hydroxylation on specific proline residues (Pro402 and Pro564 in human HIF-1α; Pro405 and Pro531 in human HIF-2α) within its oxygen-dependent degradation domain (ODD) [30–36] and is necessary for its rapid proteasomal degradation under normoxic conditions.”
BackgroundYeo, E.-J. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0233-3 · Cited by 175
The von Hippel–Lindau tumor suppressor protein: new insights into oxygen sensing and cancer
Kim, W., & Kaelin, W. G. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00010-2 · Cited by 175
Koivunen, P., Tiainen, P., Hyvärinen, J., Williams, K. E., Sormunen, R., Klaus, S. J., Kivirikko, K. I., & Myllyharju, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704988200 · Cited by 145
ROS: Really involved in Oxygen Sensing
Kaelin, W. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.006 · Cited by 173
HIF in Kidney Disease and Development
Gunaratnam, L., & Bonventre, J. V. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008070804 · Cited by 173
Liu, Y. V., Hubbi, M. E., Pan, F., McDonald, K. R., Mansharamani, M., Cole, R. N., Liu, J. O., & Semenza, G. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705015200 · Cited by 148
HIF hydroxylation and cellular oxygen sensing
Metzen, E., & Ratcliffe, P. J. (2004) · Biological Chemistry · doi:10.1515/bc.2004.016 · Cited by 172
“, 2001), Drosophila melanogaster (Bruick and McKnight, 2001; Lavista-Llanos et al., 2002), mouse (Taylor, 2001), and rat (D’Angelo et al.”
BackgroundFluorine-containing drugs approved by the FDA in 2021
He, J., Li, Z., Dhawan, G., Zhang, W., Sorochinsky, A. E., Butler, G., Soloshonok, V. A., & Han, J. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.06.001 · Cited by 172
Impact of intracellular innate immune receptors on immunometabolism
Chou, W.-C., Rampanelli, E., Li, X., & Ting, J. P.-Y. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00780-y · Cited by 172
“Once in the cytosol, succinate inhibits prolyl hydroxylases and thus promotes HIF-1α stabilization and activation [94, 97], resulting in the upregulation of glycolytic enzymes [3, 11, 38, 98].”
BackgroundHsieh, M. M., Linde, N. S., Wynter, A., Metzger, M., Wong, C., Langsetmo, I., Lin, A., Smith, R., Rodgers, G. P., Donahue, R. E., et al. (2007) · Blood · doi:10.1182/blood-2007-02-073254 · Cited by 171
Vangeison, G., Carr, D., Federoff, H. J., & Rempe, D. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5323-07.2008 · Cited by 171
“During hypoxia, HIF-1 protein is stabilized by a decrease in activity of prolyl hydroxylases, binds to its Per-Arnt-Sim binding partner HIF-1 , and translocates to the nucleus to bind to hypoxiaresponsive cis-elements (HREs) (Bruick and McKnight, 2001; Jaakkola et al., 2001).”
BackgroundBerchner-Pfannschmidt, U., Yamac, H., Trinidad, B., & Fandrey, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607065200 · Cited by 155
Cioffi, C. L., Qin Liu, X., Kosinski, P. A., Garay, M., & Bowen, B. R. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00453-4 · Cited by 170
Flamme, I., Oehme, F., Ellinghaus, P., Jeske, M., Keldenich, J., & Thuss, U. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111838 · Cited by 170
“Whereas HIF-b PLOS ONE | www.plosone.org 1 November 2014 | Volume 9 | Issue 11 | e111838 is constitutively expressed, the availability of HIF-a is under the control of a family of three enzymes, the HIF prolyl hydroxylases (also known as prolyl hydroxylase domain-containing protein 1–3, PHD1–3 or C. elegans EGL9 homol…”
Hypoxia-activated autophagy accelerates degradation of SQSTM1/p62
Pursiheimo, J.-P., Rantanen, K., Heikkinen, P. T., Johansen, T., & Jaakkola, P. (2008) · Oncogene · doi:10.1038/onc.2008.392 · Cited by 171
Oxygen-Dependent and -Independent Regulation of HIF-1alpha
Chun, Y. S., Kim, M. S., & Park, J. W. (2002) · Journal of Korean Medical Science · doi:10.3346/jkms.2002.17.5.581 · Cited by 152
“Recently, three isoforms of HIF-1-prolyl hydroxylase (PHD13) were found to be able to hydroxylate the motif targeted by pVHL (27, 28).”
BackgroundThe ubiquitin system: pathogenesis of human diseases and drug targeting
Ciechanover, A., & Schwartz, A. L. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.018 · Cited by 169
Sensing and responding to hypoxia via HIF in model invertebrates
Gorr, T. A., Gassmann, M., & Wappner, P. (2006) · Journal of Insect Physiology · doi:10.1016/j.jinsphys.2006.01.002 · Cited by 169
Role of melatonin in controlling angiogenesis under physiological and pathological conditions
Ma, Q., Reiter, R. J., & Chen, Y. (2020) · Angiogenesis · doi:10.1007/s10456-019-09689-7 · Cited by 169
“causes the degradation of HIF-1α by the proteasome [62].”
BackgroundHIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
Bishop, T., & Ratcliffe, P. J. (2015) · Circulation Research · doi:10.1161/circresaha.117.305109 · Cited by 169
“HIF prolyl hydroxylation is catalyzed by 3 closely related enzymes termed prolyl hydroxylase domain (PHD) 1, 2, and 3; otherwise known as Egln2, 1, and 3.(6,7) HIF asparaginyl hydroxylation is catalyzed by a single enzyme, factor inhibiting HIF (FIH).”
Stalking intermediates in oxygen activation by iron enzymes: Motivation and method
Bollinger, J. M., Jr., & Krebs, C. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.01.022 · Cited by 168
The cancer stem cell niche(s): The crosstalk between glioma stem cells and their microenvironment
Filatova, A., Acker, T., & Garvalov, B. K. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.10.008 · Cited by 167
Moslehi, J., Minamishima, Y. A., Shi, J., Neuberg, D., Charytan, D. M., Padera, R. F., Signoretti, S., Liao, R., & Kaelin, W. G. (2010) · Circulation · doi:10.1161/circulationaha.109.922427 · Cited by 167
Oxygen-Regulated β 2 -Adrenergic Receptor Hydroxylation by EGLN3 and Ubiquitylation by pVHL
Xie, L., Xiao, K., Whalen, E. J., Forrester, M. T., Freeman, R. S., Fong, G., Gygi, S. P., Lefkowitz, R. J., & Stamler, J. S. (2009) · Science Signaling · doi:10.1126/scisignal.2000444 · Cited by 148
“Oxygen dependence is mediated by a family of enzymes (EGLN 1 to 3) that catalyze hydroxylation of specific prolyl residues within the a subunits of HIF (18, 19).”
BackgroundOlson, N., & van der Vliet, A. (2011) · Nitric Oxide · doi:10.1016/j.niox.2010.12.010 · Cited by 156
Natarajan, R., Salloum, F. N., Fisher, B. J., Kukreja, R. C., & Fowler, A. A. (2006) · Circulation Research · doi:10.1161/01.res.0000197816.63513.27 · Cited by 166
Metadata
- Authors
- Bruick, R. K., & McKnight, S. L.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- McKnight, Steven L.
- ORCID
- McKnight, Steven L.
- Venue
- Science
- Published
- 2001-11-09
- Volume
- 294
- Issue
- 5545
- Pages
- 1337-1340
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2042216712
- Cited by
- 2,549
- References
- 27
- Citations by year
- 2026: 42 · 2025: 51 · 2024: 67 · 2023: 65 · 2022: 90 · 2021: 95 · 2020: 80 · 2019: 90 · 2018: 103 · 2017: 98 · 2016: 113 · 2015: 109 · 2014: 104 · 2013: 115 · 2012: 114
- FWCI
- 42.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
- Keywords
- prolyl 4-hydroxylase, hypoxia-inducible factor, HIF-1α, oxygen sensing, proline hydroxylation, protein degradation, ubiquitin ligase, post-translational modification, lactate dehydrogenase, Drosophila melanogaster, normoxia
- MeSH terms
- Amino Acid Sequence, Animals, Cell Line, Cloning, Molecular, DNA-Binding Proteins, Drosophila melanogaster, Humans, Hydroxylation, Hydroxyproline, L-Lactate Dehydrogenase, Molecular Sequence Data, Mutation, Nuclear Proteins, Oxygen, Procollagen-Proline Dioxygenase, Recombinant Proteins, RNA, Double-Stranded, Substrate Specificity, Transcription Factors, Transfection, Cell Hypoxia, Gene Expression Regulation, Enzymologic, Sequence Alignment, Conserved Sequence, Genes, Insect, Genes, Reporter, Amino Acid Substitution, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.